- IceCure Medical Adjourns Shareholder Meeting After Initial Quorum Shortfall
- WD-40 Completes Sale of X-14, Carpet Fresh Brands to Malco Products
- Wolverine World Wide Declares Quarterly Dividend of $0.10 Per Share
- Capital Southwest Q2 FY27 pre-tax net investment income rises 6% from prior quarter to $37.2 million
- Gibson Energy Declares Quarterly Dividend of CAD 0.45 per Share
- Whitehawk Minerals Amends Credit Agreement to Permit Series E, Series F Preferred Stock Issuance
- Visa Director Lloyd Carney Reports Disposal of $251,244.40 in Common Shares
- Hershey Trust Reports Disposal of $3.26 Million in Hershey Common Shares
- Advanced Energy Q3 2026 net income more than doubles year over year to $115.6 million; Q3 2026 revenue rises 50% year over year to $696.4 million
- Syndax Names Aaron A. Ondrey CFO, Effective Nov. 9
- Orexo board sets terms for SEK 253 million rights issue
- AquaBounty Obtains Up to $1 Million Bridge Loan From Commas International
- Travere Therapeutics swings to Q3 net loss of $52.34 million
- BRIEF-Biomarin Pharmaceutical Q3 EPS USD -0.63
- SBA Communications Q3 2026 net income attributable to company falls to $231.31 million
- Vertex Q3 2026 net income falls 40% year over year to $653.6 million
- Janux Therapeutics Hosts Virtual Event to Present Initial JANX011 Phase 1 Data
- Daily Journal Grants CEO Steven Myhill-Jones 800 Restricted Stock Units
- Gibson Energy Q3 adjusted EBITDA rises 31% to CAD 192.89 million
- Bambusa Therapeutics Grants CEO Shanshan Xu 758,204 Performance-Based Restricted Stock Units
- Dianthus Therapeutics Participates in Five Investor Conferences
- Astec Industries Declares Quarterly Dividend of $0.13 Per Share
- BRIEF-Travere Therapeutics Q3 EPS USD -0.55
- BRIEF-Diamondback Energy Q3 Adjusted EPS USD 5.86 Vs. IBES Estimate USD 5.46
- BRIEF-Advanced Energy Industries Q3 Gross Margin 41.5%
- BRIEF-SBA Communications Q3 Adjusted FFO Per Share USD 3.19
- BRIEF-Syndax Pharmaceuticals Q3 Operating Expenses USD 125.193 Million
- BRIEF-Gibson Energy Q3 Dividend CAD 0.45
- Vertex Pharmaceuticals Raises 2026 View To Rev $13.15B-$13.25B >VRTX
- PMGC Holdings Agrees to Buy USD 1.85 Million in Nuclea Canada Secured Debentures
- IZEA grants CFO Peter Biere 26,311 restricted stock units
- Assembly Biosciences Participates in Three Investor Conferences
- Kazia Therapeutics Delays Annual Report to Complete Internal Control Review
- CVRx to Participate in Canaccord Genuity and Jefferies Investor Conferences
- Reklaim Proposes Voluntary Early Debt Conversion Into Shares
- Roku Q3 2026 net income rises to $183.34 million year over year; Q3 2026 net revenue climbs 24% to $1.5 billion
- ReNew Q2 FY27 net profit jumps 37% year over year to INR 6.42 billion
- C4 Therapeutics Grants New Employee Stock Options for 85,480 Shares
- Xenon Pharmaceuticals Sets Third-Quarter Results Release
- Lamb Weston Announces Participation in Two Investor Conferences
- BRIEF-Lattice Semiconductor Q3 Adjusted EPS USD 0.72 Vs. IBES Estimate USD 0.55
- Syndax Pharmaceuticals 3Q Rev $83.3M >SNDX
- Frontier Group: Trevor Stedke, Senior VP, Ops, and Alex Clerc, Senior VP, Customers, Will Leave Co. Effective Nov. 13
- Diamondback Energy 3Q Rev $5.43B >FANG
- Vertex Pharmaceuticals 3Q Net $653.6M >VRTX
- Avalo Therapeutics Participates in Guggenheim, Stifel Healthcare Conferences
- -- Earnings Flash (SNDX) Syndax Pharmaceuticals, Inc. Reports Q3 Revenue $83.3M, vs. FactSet Est of $81.4M
- --Earnings Flash (FANG) Diamondback Energy Posts Q3 Adjusted EPS $5.86, vs. FactSet Est of $5.72
- -- Earnings Flash (CSWC) Capital Southwest Corporation Reports Q2 Investment Income $67.2M
- --Roku Reports Q3 Streaming Hours at 39.9 Billion vs FactSet Analyst Consensus of 39.8 Billion
- -- Earnings Flash (VVX) V2X, Inc. Posts Q3 Adjusted EPS $1.64 per Share, vs. FactSet Est of $1.50
- -- Earnings Flash (SBRA) Sabra Health Care REIT, Inc. Reports Q3 Revenue $249.6M, vs. FactSet Est of $236.6M
- -- Earnings Flash (VVX) V2X, Inc. Reports Q3 Revenue $1.27B, vs. FactSet Est of $1.22B
- -- Earnings Flash (ALSN) Allison Transmission Holdings Inc. Reports Q3 Revenue $1.53B, vs. FactSet Est of $1.47B
- -- Earnings Flash (WAY) Waystar Holding Corp. Posts Q3 Adjusted EPS $0.44 per Share, vs. FactSet Est of $0.41
- -- Earnings Flash (ICHR) Ichor Holdings, Ltd. Posts Q3 Adjusted EPS $0.63 per Share, vs. FactSet Est of $0.45
- -- Earnings Flash (HNGE) Hinge Health, Inc. Reports Q3 Revenue $235.0M, vs. FactSet Est of $224.8M
- -- Earnings Flash (AEHR) Aehr Test Systems Posts Q1 Adjusted EPS $0.28 per Share
- -- GUIDANCE: (HNGE) Hinge Health, Inc. Expects Q4 Revenue Range $249.0M - $251.0M
- -- GUIDANCE: (PLTR) Palantir Now Expects 2026 Revenue Range $8.530B-$8.534B, vs. FactSet Est of $8.21B
- --Earnings Flash (ROKU) Roku Posts Q3 EPS $1.20, vs. FactSet Est of $0.53
- --Earnings Flash (ROKU) Roku Posts Q3 Revenue $1.50B, vs. FactSet Est of $1.41B
- -- Earnings Flash (JAN) Janus Living, Inc. Reports Q3 Revenue $268.3M, vs. FactSet Est of $243.2M
- Vertex Pharmaceuticals Q3 Adjusted Earnings Fall, Revenue Rises
- -- Earnings Flash (ADEA) Adeia Inc. Posts Q3 Adjusted EPS $0.21 per Share, vs. FactSet Est of $0.30
- -- Earnings Flash (HNGE) Hinge Health, Inc. Posts Q3 Adjusted EPS $0.71 per Share, vs. FactSet Est of $0.58
- -- Earnings Flash (BWXT) BWX Technologies, Inc. Posts Q3 Adjusted EPS $1.26 per Share, vs. FactSet Est of $1.18
- -- Earnings Flash (WAY) Waystar Holding Corp. Reports Q3 Revenue $325.6M, vs. FactSet Est of $323.4M
- -- GUIDANCE: (PLTR) Palantir Expects Q4 Revenue Range $2.649B-$2.653B, vs. FactSet Est of $2.46B
- -- Earnings Flash (BWXT) BWX Technologies, Inc. Reports Q3 Revenue $953.0M, vs. FactSet Est of $970.5M
- -- Earnings Flash (HLIT) Harmonic Inc. Reports Q3 Revenue $148.8M
- --GUIDANCE: (O) Realty Income Expects 2026 AFFO Range $4.45-$4.46, vs. FactSet Est of $4.44
- -- Earnings Flash (JAZZ) Jazz Pharmaceuticals plc Reports Q3 Revenue $1.24B, vs. FactSet Est of $1.21B
- -- Earnings Flash (UPWK) Upwork Inc. Reports Q3 Revenue $185.6M, vs. FactSet Est of $180.2M
- -- Earnings Flash (O) Realty Income Corporation Posts Q3 AFFO $1.12 per Share, vs. FactSet Est of $1.10
- -- Earnings Flash (PLTR) Palantir Technologies Inc. Posts Q3 Adjusted EPS $0.44 per Share, vs. FactSet Est of $0.41
- --Palantir Technologies Q3 US Government Revenue at $953 Million vs FactSet Analyst Consensus of $854.1 Million; US Commercial Revenue at $984 Million vs Consensus of $925.1 Million
- -- Earnings Flash (O) Realty Income Corporation Reports Q3 Revenue $1.62B, vs. FactSet Est of $1.43B
- -- Earnings Flash (JAZZ) Jazz Pharmaceuticals plc Posts Q3 Adjusted Loss $3.88 per Share, vs. FactSet Est of $-4.05
- -- Earnings Flash (WMB) The Williams Companies, Inc. Posts Q3 Adjusted EPS $0.54 per Share, vs. FactSet Est of $0.54
- -- Earnings Flash (PLTR) Palantir Technologies Inc. Reports Q3 Revenue $2.31B, vs. FactSet Est of $2.18B
- -- Earnings Flash (DOC) Healthpeak Properties, Inc. Reports Q3 Revenue $820.9M, vs. FactSet Est of $889M
- --Earnings Flash (O) Realty Income Posts Q3 AFFO $1.12 a Share, vs. FactSet Est of $1.10
- -- Earnings Flash (WMB) The Williams Companies, Inc. Reports Q3 Revenue $3.22B, vs. FactSet Est of $2.99B
- Sector Update: Financial Stocks Higher Late Afternoon
- -- Earnings Flash (TVTX) Travere Therapeutics, Inc. Reports Q3 Revenue $224.6M, vs. FactSet Est of $195.3M
- -- Earnings Flash (TVTX) Travere Therapeutics, Inc. Posts Q3 Adjusted Loss $0.31 per Share
- -- Earnings Flash (BMRN) BioMarin Pharmaceutical Inc. Posts Q3 Adjusted EPS $0.23 per Share
- -- Earnings Flash (BMRN) BioMarin Pharmaceutical Inc. Reports Q3 Revenue $1.02B, vs. FactSet Est of $1.02B
- --GUIDANCE: (SBAC) SBA Communications Expects 2026 Revenue Range $2.83B-$2.86B, vs. FactSet Est of $2.86B
- -- Earnings Flash (CRSP) CRISPR Therapeutics AG Reports Q3 Revenue $12.7M, vs. FactSet Est of $14.8M
- --GUIDANCE: (SBA) SBA Communications Expects 2026 AFFO Range $12.15-$12.37
- --Earnings Flash (SBAC) SBA Communications Posts Q3 AFFO $3.19 a Share, vs. FactSet Est of $3.10
- -- Earnings Flash (VRTX) Vertex Pharmaceuticals Incorporated Posts Q3 Adjusted EPS $4.76 per Share, vs. FactSet Est of $4.82
- -- Earnings Flash (VRTX) Vertex Pharmaceuticals Incorporated Reports Q3 Revenue $3.44B, vs. FactSet Est of $3.42B
- -- GUIDANCE: (VRTX) Vertex Pharmaceuticals Expects 2026 Revenue Range $13.15B-$13.25B, vs. FactSet Est of $13.26B
- -- GUIDANCE: (AEIS) Advanced Energy Industries, Inc. Expects Q4 Revenue Range $710.0M - $760.0M
- -- Earnings Flash (AEIS) Advanced Energy Industries, Inc. Posts Q3 Adjusted EPS $3.65 per Share, vs. FactSet Est of $3.04
- -- GUIDANCE: (AEIS) Advanced Energy Industries, Inc. Expects Q4 Adjusted EPS Range $3.60 - $4.20
- -- Earnings Flash (AEIS) Advanced Energy Industries, Inc. Reports Q3 Revenue $696.4M, vs. FactSet Est of $644.9M
